17 Results

People

  1. Motzer
    Motzer
  2. Abou-Alfa
    Abou-Alfa
  3. Maki
    Maki
  4. Trippett
    Trippett
  5. Abrey
    Abrey
  6. Baum
    Baum
  7. Diaz
    Diaz
  8. Harding
    Harding
  9. Lassman
    Lassman
  10. Millang
    Millang

Groups

  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Gastrointestinal Oncology Service (3)
  4. Genitourinary Oncology Service (3)
  5. Center for Hematologic Malignancies (2)
  6. Hematologic Malignancies Service (2)
  7. Pediatric Leukemia (2)
  8. Pediatrics, Department of (2)
  9. Breast Medicine Service (1)
  10. Cardiology (1)
  1. "Springer"
  2. "Targeted Oncology"
Formats
  1. Journal Article (16)
  2. Review (1)
Groups
  1. Department of Medicine (9)
  2. Solid Tumor Oncology Division (9)
  3. Gastrointestinal Oncology Service (3)
  4. Genitourinary Oncology Service (3)
  5. Center for Hematologic Malignancies (2)
  6. Hematologic Malignancies Service (2)

More Groups

People
  1. Robert Motzer (3)
  2. Ghassan Abou-Alfa (2)
  3. Robert Maki (2)
  4. Tanya Trippett (2)
  5. Amin Yaqubie (1)
  6. Andrew Lassman (1)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (2)
  4. 2020 (1)
  5. 2018 (1)
  6. 2016 (1)

More Years

Publications
  1. Targeted Oncology (17)
Publishers
  1. Springer (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modelling the effectiveness of tepotinib in comparison to standard-of-care treatments in patients with advanced non-small cell lung cancer (NSCLC) harbouring METex14 skipping in the UK
    Journal Article

    Batteson, R.; Hook, E.; Wheat, H.; Hatswell, A. J.; Vioix, H.; McLean, T.; Alexopoulos, S. T.; Baijal, S.; Paik, P. K.
    Targeted Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b/2 study of alpelisib in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Journal Article

    Razak, A. R. A.; Wang, H. M.; Chang, J. Y.; Ahn, M. J.; Munster, P.; Blumenschein, G.; Solomon, B.; Lim, D. W. T.; Hong, R. L.; Pfister, D.; more...
    Targeted Oncology (2023)

    Fulltext@MSK | Save
  • Population pharmacokinetics and exposure–response with teclistamab in patients with relapsed/refractory multiple myeloma: Results from MajesTEC-1
    Journal Article

    Miao, X.; Wu, L. S.; Lin, S. X. W.; Xu, Y.; Chen, Y.; Iwaki, Y.; Kobos, R.; Stephenson, T.; Kemmerer, K.; Uhlar, C. M.; more...
    Targeted Oncology (2023)

    Fulltext@MSK | Save
  • Summary of research: Adjuvant nivolumab plus ipilimumab versus placebo for localized renal cell carcinoma after nephrectomy (CheckMate 914): A double-blind, randomized, phase 3 trial
    Journal Article

    Motzer, R. J.; Russo, P.; Grünwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O.; Buti, S.; Barthélémy, P.; Goh, J. C.; Ye, D.; more...
    Targeted Oncology (2023)

    Fulltext@MSK | Save
  • First-in-human study of INCB062079, a fibroblast growth factor receptor 4 inhibitor, in patients with advanced solid tumors
    Journal Article

    Harding, J. J.; Jungels, C.; Machiels, J. P.; Smith, D. C.; Walker, C.; Ji, T.; Jiang, P.; Li, X.; Asatiani, E.; Van Cutsem, E.; more...
    Targeted Oncology (2023)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on overall and progression-free survival in patients receiving systemic therapy for intrahepatic cholangiocarcinoma
    Journal Article

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B.; Ren, H.; Féliz, L.
    Targeted Oncology (2022)

    Fulltext@MSK | Save
  • Cobimetinib in pediatric and young adult patients with relapsed or refractory solid tumors (iMatrix-cobi): A multicenter, phase I/II study
    Journal Article

    Trippett, T.; Toledano, H.; Campbell Hewson, Q.; Verschuur, A.; Langevin, A. M.; Aerts, I.; Howell, L.; Gallego, S.; Rossig, C.; Smith, A.; more...
    Targeted Oncology (2022)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition in colorectal cancer: Microsatellite instability and beyond
    Review

    Cohen, R.; Rousseau, B.; Vidal, J.; Colle, R.; Diaz, L. A. Jr; André, T.
    Targeted Oncology (2020)

    Fulltext@MSK | Save
  • Targeting the proteasome in refractory pediatric leukemia cells: Characterization of effective cytotoxicity of carfilzomib
    Journal Article

    Swift, L.; Jayanthan, A.; Ruan, Y.; Anderson, R.; Boklan, J.; Trippett, T.; Narendran, A.
    Targeted Oncology (2018)

    Fulltext@MSK | Save
  • Effect of renal impairment on the pharmacokinetics and safety of axitinib
    Journal Article

    Chen, Y.; Rini, B. I.; Motzer, R. J.; Dutcher, J. P.; Rixe, O.; Wilding, G.; Stadler, W. M.; Tarazi, J.; Garrett, M.; Pithavala, Y. K.
    Targeted Oncology (2016)

    Fulltext@MSK | Save